Lumida
/GTHX
⌘K
G1 Therapeutics Inc

G1 Therapeutics Inc

GTHX
$7.15USD+0.00%+0.00 today

MARKET CAP

377.2M

P/E (TTM)

FWD P/E

DAY RANGE

$7 – $7

52W RANGE

$1
$7
STATEMENT·Income statement
USD · GAAP
METRICFY 2020FY 2021FY 2022FY 2023TREND
Sales, Adj.$45.3M$31.5M$51.3M$82.5M
YoY %-30.5%+63.0%+60.8%
P / Sales
EV / Sales
Gross Profit, Adj.$45.3M$31.5M$51.3M$82.5M
YoY %-30.5%+63.0%+60.8%
Margin %100.0%100.0%100.0%100.0%
EV / Gross Profit
EBITDA, Adj.$-95.9M$-142.0M$-135.6M$-39.0M
YoY %+25.5%-48.1%+4.5%+71.2%
Margin %-211.8%-451.1%-264.4%-47.3%
EV / EBITDA
EBIT$-96.5M$-142.5M$-136.2M$-39.5M
YoY %+25.2%-47.7%+4.4%+71.0%
Margin %-213.0%-452.6%-265.4%-47.9%
EV / EBIT
Net Income$-99.3M$-148.4M$-147.6M$-48.0M
YoY %+18.9%-49.5%+0.5%+67.5%
Net Margin-219.2%-471.3%-287.6%-58.1%
EPS (GAAP)-$2.62-$3.54-$3.38-$0.93
YoY %+19.9%-35.1%+4.5%+72.5%